Copyright
©The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
World J Gastrointest Surg. Aug 27, 2024; 16(8): 2426-2435
Published online Aug 27, 2024. doi: 10.4240/wjgs.v16.i8.2426
Published online Aug 27, 2024. doi: 10.4240/wjgs.v16.i8.2426
Surgical resection and neoadjuvant therapy in patients with gastric cancer and ovarian metastasis: A real-world study
Hui-Ping Yan, Zhe-Ling Chen, School of Public Health, Hangzhou Medical College, Hangzhou 310000, Zhejiang Province, China
Hui-Ping Yan, Hong-Rui Lu, Liu Yang, Zhe-Ling Chen, Cancer Center, Department of Medical Oncology, Zhejiang Provincial People’s Hospital (Affiliated People’s Hospital), Hangzhou 310000, Zhejiang Province, China
Yu-Xia Zhang, Affiliated Bijie Hospital, Zhejiang Provincial People’s Hospital, Bijie 551700, Guizhou Province, China
Co-first authors: Hui-Ping Yan and Hong-Rui Lu.
Author contributions: Yan HP and Lu HR contributed to the study equally, they are the co-first authors of this article. Yang L and Chen ZL made contribution to conception and design; Yan HP analyzed and interpreted the data; Yan HP, Lu HR, and Zhang YX performed the data collection; Yan HP and Lu HR completed the final version of the article. All authors contributed to this study and agreed to submit the final version.
Institutional review board statement: This study was approved by the ethics committee of our institution (Zhejiang Provincial People’s Hospital Ethics Committee).
Informed consent statement: The informed consent was exempted by the ethics committee.
Conflict-of-interest statement: All the authors report no relevant conflicts of interest for this article.
Data sharing statement: No additional data are available.
STROBE statement: The authors have read the STROBE Statement-checklist of items, and the manuscript was prepared and revised according to the STROBE Statement-checklist of items.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Zhe-Ling Chen, MD, Attending Doctor, School of Public Health, Hangzhou Medical College, No. 481 Binwen Road, Hangzhou 310000, Zhejiang Province, China. 383974903@qq.com
Received: March 17, 2024
Revised: June 4, 2024
Accepted: June 26, 2024
Published online: August 27, 2024
Processing time: 152 Days and 11.3 Hours
Revised: June 4, 2024
Accepted: June 26, 2024
Published online: August 27, 2024
Processing time: 152 Days and 11.3 Hours
Core Tip
Core Tip: This study found that patients with gastric cancer ovarian metastases (GCOM) who underwent metastatic resection had significantly longer survival and a significantly better prognosis than patients with GCOM who did not undergo surgery. It also found that patients with GCOM who underwent surgery did or did not receive neoadjuvant therapy. There were no statistically significant differences in prognosis or survival time. Finally, a group of patients who would benefit from metastatic resection was screened.